FORWARD FEATURES CALENDAR

Deals

Lazard strikes $575m deal to acquire Campbell Lutyens

Lazard has agreed to acquire private markets advisory specialist Campbell Lutyens in a transaction valued at approximately $575m, a move that will see the creation of a new dedicated private capital advisory business, according to a report by Reuters.

Entrepreneur Equity Partners pays 70% premium for Benfica stake

Portuguese football club SL Benfica has agreed a minority stake sale to Entrepreneur Equity Partners at a valuation implying a significant premium over recent trading levels, underscoring growing international demand for European football assets, according to a report by Bloomberg.

CVC eyes €9bn Nexi takeover

Private investment firm CVC Capital Partners is evaluating a potential €9bn ($10.5bn) bid for Italian payments group Nexi, as it revisits a target it has previously explored acquiring, according to a report by Reuters.

EQT-backed Virtusa explores $1bn India IPO

Virtusa, the global IT services provider owned by European private investment major EQT, is assessing plans for an initial public offering in India that could raise at least $1bn and value the business at $7bn or more, according to a report by Reuters.

Stonepeak and Bernhard near $6bn deal for Louisiana utility Cleco Power

A consortium comprising Stonepeak Partners and Bernhard Capital Partners is nearing an agreement to acquire Louisiana-based utility Cleco Power in a transaction valued at approximately $5.75bn to $6 billion, according to a report by Bloomberg citing unnamed people familiar with the matter.

PE-backed Digital Edge explores options including $10bn sale

Digital Edge, the Asia-Pacific data centre operator backed by Stonepeak Partners, is exploring strategic options including a potential partial or full sale that could value the business at up to $10bn, according to a report by Bloomberg citing unnamed people familiar with the matter.

Astorg strikes $1bn-plus deal for Thermo Fisher microbiology business

TOP STORY: Thermo Fisher Scientific has agreed to divest its microbiology division to private equity firm Astorg in a deal valued at approximately $1.08bn, according to a company statement. The transaction will be funded through a combination of cash proceeds and a $50m seller note.

Events

12 November, 2026 – 5:00 pm

Directory Listings